Addus HomeCare (ADUS) PT Raised to $119 at TD Cowen
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St set for higher open as Democrats win Congress; data center stocks slide
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts ADUS Hot Sheet
Price: $126.55 --0%
Rating Summary:
15 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Rating Summary:
15 Buy, 2 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 15 | Down: 20 | New: 12
Join SI Premium – FREE
TD Cowen analyst Ryan Langston raised the price target on Addus HomeCare (NASDAQ: ADUS) to $119.00 (from $105.00) while maintaining a Buy rating.
The analyst commented, "ADUS posted a 1Q24 EBITDA result 7% better than consensus. We are raising our annual estimates in 2024 by 5% and 2025 by 4% mainly on better than expected G&A leverage and higher PCS rates. We raise our price target to 119 and reiterate our Buy rating. "
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seagate Technology (STX) PT Lowered to $750 at UBS
- AMD (AMD) PT Raised to $650 at Piper Sandler
- Coloplast A/S (COLOB:DC) (CLPBY) PT Raised to DKK465 at Bernstein SocGen Group
Create E-mail Alert Related Categories
Analyst Comments, Analyst PT ChangeRelated Entities
Cowen & CoSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
